Rationale for the development of an engineered sporozoite malaria vaccine

Adv Immunol. 1989;45:283-334. doi: 10.1016/s0065-2776(08)60695-1.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Antigens, Protozoan / genetics
  • Humans
  • Immunotherapy*
  • Malaria / immunology
  • Malaria / prevention & control*
  • Plasmodium / genetics
  • Plasmodium / growth & development
  • Plasmodium / immunology
  • T-Lymphocytes / immunology
  • Vaccines, Synthetic* / therapeutic use

Substances

  • Antigens, Protozoan
  • Vaccines, Synthetic